Clearwater Paper Corporation reported flat net sales of $386.4 million for the fourth quarter of 2025 compared to $387.1 million in the fourth quarter of 2024. Net income for the quarter was $38.3 million, or $2.39 per diluted share, a substantial decrease from $199.1 million in the prior year, which included a $307 million gain on the sale of the tissue division. Adjusted EBITDA from continuing operations improved to $19.8 million from $9.5 million in the fourth quarter of 2024.
Net sales remained flat at $386.4 million in Q4 2025 compared to $387.1 million in Q4 2024.
Net income significantly decreased to $38.3 million in Q4 2025 from $199.1 million in Q4 2024, largely due to the absence of a prior-year gain on the sale of the tissue division.
Adjusted EBITDA from continuing operations improved to $19.8 million in Q4 2025, up from $9.5 million in Q4 2024.
Diluted EPS was $2.39 in Q4 2025, down from $11.91 in Q4 2024.
Clearwater Paper anticipates production disruptions and higher operating costs in early 2026 due to severe weather, resulting in an estimated $20 million reduction in Adjusted EBITDA. The company expects a medium-term recovery driven by demand growth, lower imports, and changes in domestic supply.
Analyze how earnings announcements historically affect stock price performance